The significant improvement in ovarian PCOS syndrome using hydralazine and alendronate aromatase inhibitor FDA-approved drugs in Wistar rat models

Authors:

Abstract
No abstract available
Funding Information
  • Islamic Azad University (IR.IAU.Shiraz.REC.1401.006)

This publication has 33 references indexed in Scilit: